Tissues | Genotypesa
| Expression levels,bn |
P
c
|
---|
 |  | Negative | Low | High | NPC vs. non-NPC |
LLvs.
SL+ SS
|
---|
NPCd tissues |  |  |  |  | 4. 78 × 10-7
| 0. 035 |
 |
LL
| 5 | 11 | 21 | Â | Â |
 |
SL
| 2 | 2 | 0 | Â | Â |
 |
SS
| 0 | 0 | 0 | Â | Â |
Non-cancere
| Â | Â | Â | Â | Â | NAf
|
 |
LL
| 11 | 0 | 0 | Â | Â |
 |
SL
| 1 | 0 | 0 | Â | Â |
 |
SS
| 1 | 0 | 0 | Â | Â |
-
a
L allele, 302 or 333 bp; S allele, 243 or 272 bp.
-
bExpression levels were classified into three groups (negative, low and high expression) based on the scores of the immunohistochemistry signals.
-
cThe difference of the TERT protein level between the genotypes was assessed by a trend χ2 test. The difference of the protein level between the tumors and non-cancerous nasopharyngeal tissues was assessed by a Wilcoxon signed-ranks test.
-
dNasopharyngeal cancer
-
eNon-cancerous nasopharyngeal tissues
-
fNot available.